[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557801":3},{"organization":4,"outcomesModule":7,"designInfo":26,"detailedDescription":32,"studyPopulation":25,"armGroups":33,"interventions":49,"overallOfficials":71,"centralContacts":76,"locations":86,"responsibleParty":104,"collaborators":107,"id":113,"slug":25,"hasResults":114,"nctId":115,"briefTitle":116,"officialTitle":117,"acronym":118,"eligibilityCriteria":119,"healthyVolunteers":114,"sex":120,"minAge":121,"maxAge":122,"enrollmentInfo":123,"targetDuration":25,"studyType":126,"phases":127,"briefSummary":129,"conditions":130,"keywords":132,"overallStatus":88,"whyStopped":25,"lastUpdateSubmitDate":141,"lastUpdatePostDateStruct":142,"startDateStruct":145,"completionDateStruct":147,"leadSponsor":149,"locationsCount":150},{"fullName":5,"class":6},"University of Arizona","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":25},[9],{"measure":10,"description":11,"timeFrame":12},"CRC Screening Completion at the Individual Level","Measure the completion rate of colorectal cancer (CRC) screening at the individual level within 6 months of receiving the intervention. This will compare the proportion of participants in the post-intervention group versus the pre-intervention group.","6 months",[14,17,21],{"measure":15,"description":16,"timeFrame":12},"FIT completion","Measure the completion rate of fecal immunochemical tests (FIT) within 6 months of receiving the intervention. This will compare the proportion of participants who complete FIT in the post-intervention group versus the pre-intervention group.",{"measure":18,"description":19,"timeFrame":20},"Rate of Follow-Up Colonoscopy Completion","Track the completion rate of follow-up colonoscopy within 12 months for participants with abnormal FIT results, comparing the post-intervention versus pre-intervention groups.","12 months",{"measure":22,"description":23,"timeFrame":24},"Time to follow-up colonoscopy","Measure the time from abnormal FIT result to the completion of follow-up colonoscopy, comparing the post-intervention versus the pre-intervention groups.","Within 12 months post abnormal FIT result",null,{"allocation":27,"interventionModel":28,"interventionModelDescription":25,"primaryPurpose":29,"observationalModel":25,"timePerspective":25,"maskingInfo":30},"NON_RANDOMIZED","SEQUENTIAL","SCREENING",{"masking":31,"maskingDescription":25,"whoMasked":25},"NONE","The PRIME study aims to improve colorectal cancer (CRC) screening and follow-up among predominantly Latinx populations by using video text messages, mailed FIT kits, and patient navigation. The study will address multi-level barriers to screening, including misinformation, lack of access, and social determinants of health. The hypothesis is that a multi-component intervention will increase CRC screening rates and follow-up care, reducing disparities in CRC outcomes.",[34,42],{"label":35,"type":36,"description":37,"interventionNames":38},"Video text message, mailed FIT, and social needs navigation","EXPERIMENTAL","Tailored video text message, mailed FIT, and navigation to address patients' social needs.",[39,40,41],"Behavioral: Video text message","Behavioral: Mailed FIT","Behavioral: Social needs navigation",{"label":43,"type":44,"description":45,"interventionNames":46},"Usual care","ACTIVE_COMPARATOR","Colorectal cancer (CRC) screening offers during in-person clinic visits.",[47,48],"Behavioral: In-clinic CRC screening promotion","Behavioral: Reminders",[50,55,59,63,67],{"type":51,"name":52,"description":53,"armGroupLabels":54,"otherNames":25},"BEHAVIORAL","Video text message","Video text messages tailored to the Latinx population to educate and motivate patients to complete CRC screening.",[35],{"type":51,"name":56,"description":57,"armGroupLabels":58,"otherNames":25},"In-clinic CRC screening promotion","Stool-test orders, colonoscopy referrals.",[43],{"type":51,"name":60,"description":61,"armGroupLabels":62,"otherNames":25},"Mailed FIT","Mailed FIT kits.",[35],{"type":51,"name":64,"description":65,"armGroupLabels":66,"otherNames":25},"Social needs navigation","Patient navigation to address social needs.",[35],{"type":51,"name":68,"description":69,"armGroupLabels":70,"otherNames":25},"Reminders","Centralized text and\u002For telephone reminders for ordered tests.",[43],[72],{"name":73,"affiliation":74,"role":75},"Anne Escaron, PhD","AltaMed Health Services Corporation","PRINCIPAL_INVESTIGATOR",[77,82],{"name":78,"role":79,"phone":80,"phoneExt":25,"email":81},"Gloria Coronado, PhD","CONTACT","5039147100","gdcoronado@arizona.edu",{"name":83,"role":79,"phone":84,"phoneExt":25,"email":85},"Katherine Mendoza, MPH","8477672847","katherinemendoza@arizona.edu",[87],{"facility":74,"status":88,"city":89,"state":90,"zip":91,"country":92,"countryCode":93,"cosmosGeoPoint":94,"geoPoint":99,"contacts":100},"RECRUITING","Los Angeles","California","90040","United States","US",{"type":95,"coordinates":96},"Point",[97,98],-118.24368,34.05223,{"lat":98,"lon":97},[101],{"name":73,"role":79,"phone":102,"phoneExt":25,"email":103},"323-695-3601","aescaron@AltaMed.org",{"type":75,"investigatorFullName":105,"investigatorTitle":106,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Gloria Coronado","Principal Investigator",[108,110,111],{"name":109,"class":6},"San Diego State University",{"name":74,"class":6},{"name":112,"class":6},"Kaiser Permanente","100557801",false,"NCT06542835","Community Partnership for Telehealth Solutions to Convey Information and Enhance Care","Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity","PRIME","Inclusion Criteria:\n\n* Ages 45-64\n* Eligible for colorectal cancer (CRC) screening\n* Current patients (seen in the clinic in the last 6 months)\n* Primary speaker of English or Spanish\n* Cell phone listed in Electronic Health Record (EHR)\n* No recent history of CRC screening\n* Resides in one of the neighborhoods included in the main trial\n\nExclusion Criteria:\n\n* Colorectal disease (e.g., ulcerative colitis or colectomy)\n* Personal history of colorectal cancer\n* End-stage or life-threatening diseases\n* Known to be under hospice care\n* Living in a skilled nursing facility\n* Patients who decline research participation will be removed from the patient contact list","ALL","45 Years","64 Years",{"count":124,"type":125},6000,"ESTIMATED","INTERVENTIONAL",[128],"NA","Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.",[131],"Colorectal Cancer",[133,134,135,136,137,138,139,140],"cancer screening","telehealth","video","text messaging","patient navigation","stool testing","fecal testing","Latinx health disparities","2026-03-24",{"date":143,"type":144},"2026-03-30","ACTUAL",{"date":146,"type":144},"2024-07-31",{"date":148,"type":125},"2027-01",{"name":5,"class":6},1]